State Board of Administration of Florida Retirement System Purchases New Position in IRadimed Co. (NASDAQ:IRMD)

State Board of Administration of Florida Retirement System purchased a new stake in IRadimed Co. (NASDAQ:IRMDGet Rating) during the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund purchased 7,961 shares of the medical equipment provider’s stock, valued at approximately $270,000. State Board of Administration of Florida Retirement System owned approximately 0.06% of IRadimed at the end of the most recent reporting period.

Several other institutional investors have also bought and sold shares of the stock. Martingale Asset Management L P boosted its stake in IRadimed by 5.5% in the 1st quarter. Martingale Asset Management L P now owns 7,710 shares of the medical equipment provider’s stock valued at $346,000 after buying an additional 400 shares in the last quarter. Charles Schwab Investment Management Inc. boosted its stake in IRadimed by 4.1% in the 1st quarter. Charles Schwab Investment Management Inc. now owns 17,553 shares of the medical equipment provider’s stock valued at $788,000 after buying an additional 690 shares in the last quarter. Rhumbline Advisers boosted its stake in IRadimed by 14.4% in the 1st quarter. Rhumbline Advisers now owns 5,925 shares of the medical equipment provider’s stock valued at $266,000 after buying an additional 747 shares in the last quarter. Strs Ohio boosted its stake in IRadimed by 6.1% in the second quarter. Strs Ohio now owns 15,700 shares of the medical equipment provider’s stock worth $532,000 after purchasing an additional 900 shares in the last quarter. Finally, Advisor Group Holdings Inc. boosted its stake in IRadimed by 82.3% in the first quarter. Advisor Group Holdings Inc. now owns 2,167 shares of the medical equipment provider’s stock worth $98,000 after purchasing an additional 978 shares in the last quarter. Institutional investors and hedge funds own 44.25% of the company’s stock.

Analyst Ratings Changes

Separately, StockNews.com initiated coverage on IRadimed in a research note on Wednesday, October 12th. They issued a “buy” rating on the stock.

IRadimed Stock Down 0.6 %

IRMD stock opened at $29.22 on Tuesday. The business has a fifty day moving average of $29.13 and a 200-day moving average of $32.54. The company has a market cap of $367.18 million, a P/E ratio of 28.10 and a beta of 0.98. IRadimed Co. has a twelve month low of $26.00 and a twelve month high of $55.92.

IRadimed Company Profile

(Get Rating)

IRADIMED CORPORATION develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible medical devices, and related accessories and services in the United States and internationally. It offers MRidium MRI compatible intravenous (IV) infusion pump system with associated disposable IV tubing sets; and MRI compatible patient vital signs monitoring system.

Featured Articles

Institutional Ownership by Quarter for IRadimed (NASDAQ:IRMD)

Receive News & Ratings for IRadimed Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IRadimed and related companies with MarketBeat.com's FREE daily email newsletter.